Product Information
SEVELAMER CARBONATE 800 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2140 per EA under NDC 33342021558. Its NADAC has been published 135 times since Mar 6, 2024.
FDA first approved this application on Apr 19, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342021558
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SEVELAMER CARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA206100FDA Approved
4/19/2023
TE Code
AB
On Market Since
4/19/2023
Pharmacological Classes
Price Statistics
The NADAC for SEVELAMER CARBONATE 800 MG TAB has been published 135 times since Mar 6, 2024, and over the history we have for it it has declined 15.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2140 per EA |
|---|---|
| All-time high | $0.2799 (Jul 10, 2024) |
| All-time low | $0.1833 (Nov 20, 2024) |
| 52-week high | $0.2285 |
| 52-week low | $0.2074 |
| Median price | $0.2186 |
| Average price | $0.2211 |
| Largest weekly change | -23.8% (Jul 17, 2024) |
| Weeks tracked | 135 |
| Tracking since | Mar 6, 2024 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sevelamer Carbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphate Binder class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SEVELAMER CARBONATE 800 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER CARBONATE 800 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $0.2140 per EA (NDC 33342021558), effective Sep 30, 2026.
How has the price of SEVELAMER CARBONATE 800 MG TAB changed over time?
Over the history we have for it, the NADAC for SEVELAMER CARBONATE 800 MG TAB has declined 15.7%. It has been tracked across 135 weekly CMS publications since Mar 6, 2024.
What are the highest and lowest recorded NADAC prices for SEVELAMER CARBONATE 800 MG TAB?
Since Mar 6, 2024, the NADAC for SEVELAMER CARBONATE 800 MG TAB has ranged from a low of $0.1833 (Nov 20, 2024) to a high of $0.2799 (Jul 10, 2024), with a median of $0.2186 per EA.
Are there cheaper alternatives to SEVELAMER CARBONATE 800 MG TAB?
11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SEVELAMER CARBONATE 800 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures SEVELAMER CARBONATE 800 MG TAB?
SEVELAMER CARBONATE 800 MG TAB (NDC 33342021558) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.